Published in BMJ on January 11, 1992
Acute medical beds could be cut. BMJ (1992) 1.07
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess (2007) 5.29
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax (2001) 3.01
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax (2005) 2.09
Tuberculous meningitis. J Neurol Neurosurg Psychiatry (2000) 2.05
Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med (1997) 1.95
Evaluation of strategies for molecular fingerprinting for use in the routine work of a Mycobacterium reference unit. J Clin Microbiol (1998) 1.55
Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis (2003) 1.52
Increased risk of tuberculosis among health care workers in Samara Oblast, Russia: analysis of notification data. Int J Tuberc Lung Dis (2005) 1.46
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories. J Clin Microbiol (2002) 1.44
The use of interferon-gamma-based blood tests for the detection of latent tuberculosis infection. Eur Respir J (2006) 1.42
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis (2000) 1.42
Variability in interpretation of chest radiographs among Russian clinicians and implications for screening programmes: observational study. BMJ (2005) 1.24
Barriers to sustainable tuberculosis control in the Russian Federation health system. Bull World Health Organ (2005) 1.22
Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill (2013) 1.21
Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis (2005) 1.21
Health service providers' perceptions of barriers to tuberculosis care in Russia. Health Policy Plan (2006) 1.20
Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6. BMJ (1999) 1.19
The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res (2006) 1.19
Stigma and HIV infection in Russia. AIDS Care (2006) 1.18
Molecular epidemiology of tuberculosis in England, 1998. Int J Tuberc Lung Dis (2009) 1.09
Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions. Eur J Public Health (2005) 1.07
Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J (2009) 1.07
Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol (2004) 1.07
Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. Int J Tuberc Lung Dis (2003) 1.06
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs. Int J Tuberc Lung Dis (2012) 1.05
Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis. J Clin Microbiol (2000) 1.04
The molecular epidemiology of tuberculosis in inner London. Epidemiol Infect (2002) 1.03
A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative example. Eur J Public Health (2004) 1.02
Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study. Eur J Clin Microbiol Infect Dis (2011) 1.01
Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings. J Clin Microbiol (2011) 0.99
Tuberculosis and HIV seroprevalence in Lambeth, Southwark and Lewisham, an area of South London. Respir Med (2003) 0.98
Multidrug resistance emerging in North London outbreak. Thorax (2006) 0.98
Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage. Gut (1997) 0.95
Human microsporidiosis in African AIDS patients with chronic diarrhea. J Infect Dis (1995) 0.95
Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis (2002) 0.95
Multiple drug resistant tuberculosis: aetiology, diagnosis and outcome. Br Med Bull (1998) 0.94
MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus. Int J Tuberc Lung Dis (2010) 0.90
Social factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data. Int J Tuberc Lung Dis (2005) 0.88
Knowledge and attitudes to HIV and AIDS and sexual practices among university students in Lusaka, Zambia and London, England: are they so different? J R Soc Health (1997) 0.85
Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. Thorax (2009) 0.85
Drug resistance is not the principal barrier to effective control of tuberculosis in Zambia. J Infect Dis (1994) 0.83
Costs and outcomes of tuberculosis control in the Russian Federation: retrospective cohort analysis. Health Policy Plan (2006) 0.83
Septata intestinalis: a new microsporidian in Africa. Lancet (1994) 0.83
Laboratory diagnosis of paediatric tuberculosis in the European Union/European Economic Area: analysis of routine laboratory data, 2007 to 2011. Euro Surveill (2014) 0.82
The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge. Vaccine (2012) 0.82
Health system frailties in tuberculosis service provision in Russia: an analysis through the lens of formal nutritional support. Public Health (2005) 0.79
Endogenous Candida endophthalmitis. J R Soc Med (1993) 0.79
Antituberculosis drug resistance surveillance in Kenya, 1995. Int J Tuberc Lung Dis (1998) 0.78
European recommendations on surveillance of antituberculosis drug resistance. Euro Surveill (2000) 0.77
Intestinal mycobacteria in African AIDS patients. Lancet (1995) 0.77
The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains. Int J Tuberc Lung Dis (2012) 0.76
Fatal case of extensively drug-resistant Mycobacterium tuberculosis Beijing genotype infection in an injecting drug user, Athens, Greece, 2012. Euro Surveill (2013) 0.75
Highly active antiretroviral therapy. Lancet (1998) 0.75
Letter in response to article in Journal of Infection (Davies et al. Length of time to laboratory diagnosis 1999; 39; 205-208). J Infect (2000) 0.75